Willie R. Earley

Dr. Earley joined the Company as Senior Vice President, Head of Clinical Development in April 2022. He has over 20 years of pharmaceutical drug development experience.

Prior to joining ITCI, Dr. Earley has served in clinical development roles with increasing responsibilities at Abbvie, Allergan, Actavis, Forest, AstraZeneca and Eli Lilly and has overseen studies and supported regulatory submissions with cariprazine, asenapine, quetiapine, and olanzapine.

Prior to joining the pharmaceutical industry, Dr. Earley practiced clinical psychiatry in Chicago, and served as Clinical Assistant Professor of Psychiatry at the University of Illinois and later at the University of Chicago. Dr. Earley is a graduate of the University of Illinois at Chicago, College of Medicine where he also completed his residency in psychiatry.